JP2002512261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512261A5 JP2002512261A5 JP2000545211A JP2000545211A JP2002512261A5 JP 2002512261 A5 JP2002512261 A5 JP 2002512261A5 JP 2000545211 A JP2000545211 A JP 2000545211A JP 2000545211 A JP2000545211 A JP 2000545211A JP 2002512261 A5 JP2002512261 A5 JP 2002512261A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- component
- molecule
- radioimmunoconjugate
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010041397 CD4 Antigens Proteins 0.000 description 2
- 102100013077 CD4 Human genes 0.000 description 1
- 208000005721 HIV Infections Diseases 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19826307.4 | 1998-04-15 | ||
| DE1998126307 DE19826307A1 (de) | 1998-03-08 | 1998-04-15 | CD4-Radioimmunpharmaka zur Behandlung der HIV-Infektion |
| PCT/DE1999/001177 WO1999054954A2 (de) | 1998-04-15 | 1999-04-15 | Cd4-radioimmunpharmaka zur behandlung der hiv-infektion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002512261A JP2002512261A (ja) | 2002-04-23 |
| JP2002512261A5 true JP2002512261A5 (zh) | 2006-06-15 |
Family
ID=7870747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000545211A Pending JP2002512261A (ja) | 1998-04-15 | 1999-04-15 | Ｈｉｖ感染を治療するためのｃｄ４放射免疫薬 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1071475A2 (zh) |
| JP (1) | JP2002512261A (zh) |
| AU (1) | AU4497199A (zh) |
| DE (1) | DE19980721D2 (zh) |
| WO (1) | WO1999054954A2 (zh) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2065029A1 (en) * | 1989-09-14 | 1991-03-15 | Ellen S. Vitetta | Therapeutic compositions; methods for treatment of hiv infections |
| JPH04506460A (ja) * | 1990-01-26 | 1992-11-12 | バイオジェン，インコーポレイテッド | Ｃ４結合タンパク質の融合タンパク質 |
| GB9217124D0 (en) * | 1992-08-13 | 1992-09-23 | Antisoma Ltd | Medical treatment |
| AU6483896A (en) * | 1995-07-07 | 1997-02-10 | The Texas A & M University System | Nucleotide and amino acid sequence and uses thereof |
| DE19809785C2 (de) * | 1998-03-08 | 2000-02-10 | Wolfgang Bergter | Radioimmunpharmakon zur Behandlung der HIV-1-Infektion |
-
1999
- 1999-04-15 EP EP99927685A patent/EP1071475A2/de not_active Withdrawn
- 1999-04-15 WO PCT/DE1999/001177 patent/WO1999054954A2/de not_active Application Discontinuation
- 1999-04-15 JP JP2000545211A patent/JP2002512261A/ja active Pending
- 1999-04-15 DE DE19980721T patent/DE19980721D2/de not_active Ceased
- 1999-04-15 AU AU44971/99A patent/AU4497199A/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000329A (et) | Oraalne manustamisvorm happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod ja happes ebapüsivat toimeainet sisaldava toimeaineühiku kasutamine | |
| TR200001544T2 (tr) | Yeni bileşikler. | |
| ATE486840T1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| JP2002506648A5 (zh) | ||
| JP2002511411A5 (zh) | ||
| DK1036058T3 (da) | Adamantanderivater | |
| EE200000378A (et) | Adamantaani derivaadid | |
| CA2082948A1 (en) | Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding | |
| IT8220781A0 (it) | Bifosfonati farmacologicamente attivi, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
| EP1178786A4 (en) | PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE | |
| TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
| HUP0202537A2 (hu) | Vakcinakészítmény és eljárás annak alkalmazására | |
| ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
| HUP9900154A2 (hu) | Trovafloxacin-mezilát tabletta | |
| HK1064936A1 (en) | Use of polyclonal anti-hiv goat serum as a therapeutic agent | |
| WO2002067865A3 (en) | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof | |
| WO1991015512A3 (en) | Hiv envelope polypeptides | |
| DE60141297D1 (de) | Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper | |
| NO984540L (no) | Cytokrom P450 transduserende retrovirusvektorer | |
| ATE187890T1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
| JP2002512261A5 (zh) | ||
| SE9702794D0 (sv) | New compounds | |
| DK0815141T3 (da) | Antistof mod et fusionspolypeptid omfattende en histidinandel | |
| JP2000352551A5 (zh) | ||
| ATE219665T1 (de) | Dosisformen und deren verwendungen |